Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEPHEN J VOLK

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1598810913
CMS profile
299436
Location
PARAMOUNT, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$344.69

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $344.69 4

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $219.69 2
Janssen Pharmaceuticals, Inc $125.00 2

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEPHEN J VOLK

NPI 1598810913 · CMS profile ID 299436

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

PARAMOUNT, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598810913?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEPHEN J VOLK, NPI 1598810913, CMS profile ID 299436. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598810913?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). STEPHEN J VOLK, NPI 1598810913, CMS profile ID 299436. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598810913?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
STEPHEN J VOLK, NPI 1598810913, CMS profile ID 299436, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1598810913?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $344.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $104.1711/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788457161 CMS
Janssen Pharmaceuticals, Inc $20.8311/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788457165 CMS
ITI, Inc. $125.0106/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830191567 CMS
ITI, Inc. $94.6803/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830191563 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $598.80 26
PY2020 $188.51 4
PY2021 $344.69 4
PY2022 $46.91 1
PY2023 $366.72 4
PY2024 $483.65 6
PY2025 $853.47 8

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $606,019.12 133
PY2024 Principal investigator $514,555.10 86
PY2023 Principal investigator $208,538.60 43
PY2022 Principal investigator $558,420.91 45
PY2021 Principal investigator $274,215.89 43
PY2020 Principal investigator $1,094,352.08 67
PY2019 Principal investigator $114,933.36 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

45 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 12/30/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119111
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 11/30/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119107
Principal investigator 1 Sunovion Pharmaceuticals Inc. $1,495.00 11/18/2022 Non-covered Recipient Entity
Catalina Research Institute, LLC
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia No dispute reported 06/30/2026 867119117
Principal investigator 1 Sunovion Pharmaceuticals Inc. $6,000.00 11/18/2022 Non-covered Recipient Entity
Catalina Research Institute, LLC
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia No dispute reported 06/30/2026 867119119
Principal investigator 1 Sunovion Pharmaceuticals Inc. $1,531.00 11/18/2022 Non-covered Recipient Entity
Catalina Research Institute, LLC
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia No dispute reported 06/30/2026 867119121
Principal investigator 1 ITI, Inc. $11,322.00 11/08/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952369019
Principal investigator 1 ITI, Inc. $11,322.00 11/08/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952369073
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 10/31/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119109
Principal investigator 1 Sunovion Pharmaceuticals Inc. $2,005.20 10/14/2022 Non-covered Recipient Entity
Catalina Research Institute, LLC
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119115
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 09/30/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119105
Principal investigator 1 ITI, Inc. $587.47 09/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368643
Principal investigator 1 ITI, Inc. $587.47 09/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368695
Principal investigator 1 Sunovion Pharmaceuticals Inc. $4,010.40 09/12/2022 Non-covered Recipient Entity
Catalina Research Institute, LLC
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119113
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 08/31/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119101
Principal investigator 1 ITI, Inc. $10,458.29 08/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368343
Principal investigator 1 ITI, Inc. $10,458.29 08/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368435
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 07/30/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119103
Principal investigator 1 ITI, Inc. $1,640.49 07/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368185
Principal investigator 1 ITI, Inc. $1,640.49 07/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368233
Principal investigator 1 ITI, Inc. $18,436.88 07/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368085
Principal investigator 1 ITI, Inc. $18,436.88 07/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952368101
Principal investigator 1 Hoffmann-La Roche Limited $2,419.00 07/01/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE
TAAR1 4 FOR NEGATIVE SYMPTOMS No dispute reported 06/30/2026 950721655
Principal investigator 1 Hoffmann-La Roche Limited $7,489.00 07/01/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE
TAAR1 4 FOR NEGATIVE SYMPTOMS No dispute reported 06/30/2026 950721661
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 06/30/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119099
Principal investigator 1 ITI, Inc. $9,221.82 06/20/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367913
Principal investigator 1 ITI, Inc. $9,221.82 06/20/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367977
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 05/31/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119097
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $7,444.00 05/26/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE INC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL OF FIXED-DOSE BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN THE TREATMENT OF ADULTS WITH POST-TRAUMATIC STRESS DISORDER No dispute reported 06/30/2026 933761343
Principal investigator 1 ITI, Inc. $3,548.01 05/20/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367703
Principal investigator 1 ITI, Inc. $3,548.01 05/20/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367719
Principal investigator 1 ITI, Inc. $7,971.42 05/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367525
Principal investigator 1 ITI, Inc. $54,669.13 05/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367527
Principal investigator 1 ITI, Inc. $7,971.42 05/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367595
Principal investigator 1 ITI, Inc. $54,669.13 05/05/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367597
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 04/29/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119095
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 03/31/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119093
Principal investigator 1 ITI, Inc. $41,514.00 03/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367273
Principal investigator 1 ITI, Inc. $41,514.00 03/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367313
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 02/28/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119091
Principal investigator 1 ITI, Inc. $86,802.00 02/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367101
Principal investigator 1 ITI, Inc. $86,802.00 02/21/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952367145
Principal investigator 1 Boehringer Ingelheim International GmbH $2,498.93 02/01/2022 Non-covered Recipient Entity
Catalina Research Institute LLC
Adjunctive Computerized Cognitive Training CCT No dispute reported 06/30/2026 946884985
Principal investigator 1 Sunovion Pharmaceuticals Inc. $50.00 01/31/2022 Non-covered Recipient Entity
Catalina Research Institute
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia No dispute reported 06/30/2026 867119089
Principal investigator 1 ITI, Inc. $15,292.68 01/20/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952366843
Principal investigator 1 ITI, Inc. $15,292.68 01/20/2022 Non-covered Recipient Entity
CATALINA RESEARCH INSTITUTE LLC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF LUMATEPERONE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA No dispute reported 06/30/2026 952366887